In-depth, plain-English explainers on how Medicare covers GLP-1 medications. Written and reviewed against primary CMS.gov and FDA.gov sources.
There's no single Bridge hotline. The four numbers that actually get you help — 1-800-MEDICARE, your plan, your doctor, and free SHIP counselors — plus the scam numbers to avoid.
By GLP1Bridge Editorial · August 9, 2026
Duals qualify like everyone else — but Extra Help won't lower the $50 copay. Why the rule exists, the state Medicaid alternative, and what to do if $50/month is out of reach.
By GLP1Bridge Editorial · July 7, 2026
The $50 program expires December 31, 2027. The four possible scenarios after that, your fallback options, and why waiting to enroll is the wrong move.
By GLP1Bridge Editorial · July 6, 2026
Both cost the same flat $50/month now — so the choice comes down to results, side effects, and your health profile. The head-to-head evidence, explained.
By GLP1Bridge Editorial · July 6, 2026
The Bridge is live as of July 1. There is no sign-up form — here are the three eligibility doors, exactly what your doctor must submit, and how the flat $50 copay works.
By GLP1Bridge Editorial · July 3, 2026
Bridge copays don't count toward the annual cap — a wrinkle that changes your whole drug budget. The math, with worked examples.
By GLP1Bridge Editorial · July 3, 2026
Dehydration, muscle loss, drug interactions, surgery timing — the risks that matter more after 65, and the questions to ask your doctor.
By GLP1Bridge Editorial · July 3, 2026
Same active ingredient, different coverage. How Medicare treats each drug, prior-auth rules, and what you pay under Part D.
By GLP1Bridge Editorial · June 26, 2026
A denial isn't final. The step-by-step Medicare appeal process, redetermination timelines, and sample appeal language.
By GLP1Bridge Editorial · June 26, 2026
The CV indication that expanded Medicare coverage — who qualifies, how to get approved, and what you pay.
By GLP1Bridge Editorial · June 26, 2026
MA drug plans now participate in the $50 Bridge automatically — no switching needed. What the program guarantees, and which plan rules still matter.
By GLP1Bridge Editorial · Updated July 6, 2026
Semaglutide patent expiration, what generics are coming, and the expected cost impact for Medicare beneficiaries.
By GLP1Bridge Editorial · June 26, 2026
Medicare Part D covers Ozempic for type 2 diabetes — but not for weight loss alone. Learn what prior auth requires and what you'll pay.
By GLP1Bridge Editorial · June 28, 2026
Mounjaro is covered for type 2 diabetes under Part D. Here's how it differs from Zepbound, what prior auth requires, and what you'll pay.
By GLP1Bridge Editorial · June 28, 2026
Wegovy's list price tops $1,300/month — but covered beneficiaries often pay a fraction of that. Here's how the numbers break down.
By GLP1Bridge Editorial · June 28, 2026
Skip the reading and run the free eligibility check — it takes about a minute.
Check my eligibility →Disclaimer: GLP1Bridge.com is an independent informational resource and is not affiliated with, endorsed by, or operated by Medicare, CMS, or any drug manufacturer. This article is general education, not medical, legal, or financial advice. Coverage rules and figures can change — verify specifics with your plan and CMS.gov.